Clinical trials: Peritoneal Dialysis
Peritoneal Dialysis Solution Adverse Reaction
The Difference Between Daily and Alternative Day Use of Icodextrin
Volume overload is an important cause of technical failure in peritoneal dialysis patients. Icodextrin can provide continuous ultrafiltration, which provides a new option for peritoneal dialysis patients.
- Trial name
- NCT05943470
- Testing
- Icodextrin Peritoneal Dialysis Solution
- Volunteers
- 74 people
- Sponsor
- RenJi Hospital
End-Stage Kidney Disease, Peritoneal Dialysis
Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Peritoneal fibrosis is one of the major causes of technical failure in patients on peritoneal dialysis (PD) for long period of time.
- Trial name
- NCT01111422
- Testing
- N-acetylcysteine
- Where
- South Korea
- Volunteers
- 66 people
- Sponsor
- Ewha Womans University
Peritoneal Dialysis Complication
Characteristics and Clinical Outcomes of Peritoneal Dialysis Patients
Peritoneal dialysis patients worldwide account for about 11% of the global dialysis population. The global annual growth rate of peritoneal dialysis is estimated to be 8%, which is listed as the preferred method of renal…
- Trial name
- NCT05224466
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Peritoneal Dialysis Complication, Constipation
Evaluation of the Impact of Transit Troubles in Patients Undergoing Peritoneal Dialysis
Patients with Terminal Chronic Kidney Disease undergoing Peritoneal Dialysis (PD) often have pathophysiological factors that promote chronic constipation.
- Trial name
- TransDiPe (NCT04102527)
- Testing
- Questionnaires
- Where
- France
- Volunteers
- 180 people
- Sponsor
- Centre Hospitalier de Vichy
End Stage Renal Disease
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
Individuals with kidney disease are at a higher risk for heart and vascular diseases, including heart attacks and strokes, than those with normal kidney function.
- Trial name
- NCT01427374
- Where
- 4 sites in United States, Canada
- Volunteers
- 30 people
- Sponsor
- University of Alberta
Kidney Failure Chronic, ESRD (End-Stage Renal Disease)
Evaluation of the Application of Intelligent Applications in Patients Undergoing Peritoneal Dialysis
The goal of this clinical trial is to evaluate the value of a smart application named "Weiyin Health" in the follow-up management of patients undergoing peritoneal dialysis.
- Trial name
- NCT07612124
- Testing
- Conventional Follow-up, Weiyin Health Smart Application
- Where
- China
- Volunteers
- 223 people
- Sponsor
- The Third Xiangya Hospital of Central South University
Peritoneal Dialysis
Care Burden in Peritoneal Dialysis Caregivers.
This study aimed to explore the subjective opinions and perspectives of peritoneal dialysis caregivers regarding the caregiver burden they experience.
- Trial name
- NCT07285200
- Where
- Turkey (Türkiye)
- Volunteers
- 9 people, healthy volunteers welcome
- Sponsor
- Yuzuncu Yil University
Renal Failure, End Stage, Peritoneal Dialysis
Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
This study will analyse the effect of simvastatin on endothelium dependent venodilation in chronic renal failure patients treated by peritoneal dialysis.
- Trial name
- NCT00291863
- Testing
- Simvastatin
- Where
- Brazil
- Volunteers
- 30 people
- Sponsor
- Federal University of São Paulo
Peritoneal Dialysis, Malnutrition
Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients
Hypothesis In peritoneal dialysis (PD) patients, malnutrition, inflammation and atherosclerotic cardiovascular disease commonly coexist. The triad has been coined the "MIA syndrome".
- Trial name
- NCT00390247
- Testing
- thalidomide
- Where
- Hong Kong
- Sponsor
- Chinese University of Hong Kong
Renal Function Disorder
Effect of Diuretics on Fluid Status Control and Residual Renal Function in Peritoneal Dialysis Patients
A prospective, randomized, open-label, stratified, controlled clinical trial to evaluate whether long term furosemide therapy (1 year) would preserve urine volume and/or residual renal function (RRF) and improve fluid state in…
- Trial name
- NCT00936923
- Testing
- furosemide
- Where
- China
- Sponsor
- Sun Yat-sen University
End-Stage Renal Disease
Urgent-start Peritoneal Dialysis in ESRD Patients：A Multi-center Study
Within the last decade, urgent-start peritoneal dialysis(PD) has gained considerable interest amongst nephrologists. Several publications have provided assurances that urgent-start PD is indeed feasible and can serve patients…
- Trial name
- NCT02946528
- Testing
- urgent-start peritoneal dialysis catheter, central venous catheter
- Where
- China
- Volunteers
- 116 people
- Sponsor
- RenJi Hospital
Hyperphosphatemia Patients on Peritoneal Dialysis
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on peritoneal dialysis
- Trial name
- NCT07548853
- Testing
- 'TS-172 20~60 mg/day
- Where
- Japan
- Volunteers
- 30 people
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
Peritoneal Dialysis Complication, Renal Function Aggravated
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
This study aims to explore the role of dagliflozin in preserving the residual renal function(RRF) in peritoneal dialysis (PD) patients.
- Conditions
- Peritoneal Dialysis Complication, Renal Function Aggravated, Sodium-glucose Co-transporter-2 Inhibitors
- Trial name
- NCT06398977
- Testing
- Dapagliflozin
- Where
- China
- Volunteers
- 70 people
- Sponsor
- Sichuan Academy of Medical Sciences
Peritoneal Dialysis-associated Peritonitis, Peritoneal Dialysis (PD)
Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis
This study aims to investigate the pharmacokinetics (PK) and pharmacodynamic (PD) profiles of four commonly used antibiotics - meropenem, ampicillin, aztreonam, and ciprofloxacin - administered via intravenous (i.v.) and…
- Conditions
- Peritoneal Dialysis-associated Peritonitis, Peritoneal Dialysis (PD), Pharmacokinetics, Intravenous Administration
- Trial name
- NCT07113587
- Testing
- Application of intraperitoneal and intravenous meropenem in in automated peritoneal dialysis patients without peritonitis, Application of intraperitoneal and intravenous ampicillin in automated peritoneal dialysis patients without peritonitis, Application of intraperitoneal and intravenous aztreonam in automated peritoneal dialysis patients without peritonitis
- Where
- Austria
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Karl Landsteiner Insitute for Nephrology and Haemato-Oncology
Peritoneal Dialysis, Quality of Life
Designer Dialysis Peritoneal Dialysis
This study aims to use modified peritoneal dialysis prescriptions to achieve adequate clearance and volume removal while decreasing the number of exchanges or time spent on dialysis, evaluating maintenance of residual renal…
- Trial name
- NCT03100188
- Testing
- modified PD prescription
- Volunteers
- 7 people
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
Renal Insufficiency, Chronic, Kidney Failure, Chronic
First-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients
The goal of this first-in-human clinical trial is to examine the safety and efficacy of treatment with a new peritoneal dialysis (PD) device called WEAKID (WEarable Artificial KIDney for peritoneal dialysis).
- Conditions
- Renal Insufficiency, Chronic, Kidney Failure, Chronic, Chronic Kidney Diseases
- Trial name
- CORDIAL (NCT06314503)
- Testing
- WEAKID
- Where
- 3 sites in Italy, Netherlands and 1 more
- Volunteers
- 12 people
- Sponsor
- UMC Utrecht
Hemodialysis
Peritoneal Dialysis Versus Haemodialysis
Study in order to quantify toxin removal during dialysis
- Trial name
- NCT00752583
- Testing
- Peritoneal dialysis, Haemodialysis
- Where
- Belgium
- Volunteers
- 25 people
- Sponsor
- University Hospital, Ghent
End Stage Renal Disease
Treatment Choice and Outcomes for ESRD: Evidence From the First Year of a Nationwide Randomized Evaluation
The investigators plan to analyze the first year of a nationwide randomized-controlled trial of end stage renal disease (ESRD) treatment choice model (ETC).
- Trial name
- NCT05005572
- Testing
- Payment adjustment for home dialysis and transplant
- Where
- United States
- Volunteers
- 18,621 people
- Sponsor
- Amy Finkelstein
Insulin Resistance
Study of Keto Acid (KA) on Insulin Resistance in Peritoneal Dialysis (PD) Patients
The overarching aim of this proposal is to examine the effects of usual protein diet supplemented with keto acid (KA) on insulin sensitivity in patients on peritoneal dialysis (PD).
- Trial name
- NCT01496092
- Testing
- Keto Acid
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Peking University First Hospital
Uremia
L-Cysteine in Peritoneal Dialysis
Over the last decades, peritoneal dialysis has grown worldwide to become one of the most common modalities of renal replacement therapy, particularly in developing or newly industrialized countries, such as India, China, Korea…
- Trial name
- CINDY (NCT02050139)
- Testing
- L-cysteine
- Where
- Italy
- Volunteers
- 10 people
- Sponsor
- Mario Negri Institute for Pharmacological Research